Abstract
Over the years, there has been an exponential increase in the number of gene therapy approaches that are under investigation for the treatment of cancer. This can be attributed to our growing understanding of the molecular mechanisms that contribute to the onset and maintenance of cancer as well as to the development of gene delivery vectors. In this review, we will focus on the use of lentiviral vectors (LVs) in immuno gene therapy of cancer, as these efficacious gene delivery vehicles have come to the forefront because of their many attractive features. LVs have been successfully applied to generate potent dendritic cellbased anti-cancer vaccines and to deliver cancer-specific receptors to T-cells. Moreover, LVs are under investigation for the modulation of cancer cells. We will describe various strategies of this ‘genuine’ cancer gene therapy, amongst which transfer of suicide genes, modulation of pro- and anti-apoptotic molecules, strategies to optimize chemo- and radiotherapy, expression of molecules that affect angiogenesis or affect the immunogenicity of tumor cells. These will be discussed in view of our current knowledge of tumor immunology. Finally we will discuss some important issues and future directions to push the field forward.
Keywords: Cancer, lentiviral vector, tumor immunology
Current Molecular Medicine
Title:Lentiviral Vectors: A Versatile Tool to Fight Cancer
Volume: 13 Issue: 4
Author(s): P.U. Emeagi, C. Goyvaerts, S. Maenhout, J. Pen, K. Thielemans and K. Breckpot
Affiliation:
Keywords: Cancer, lentiviral vector, tumor immunology
Abstract: Over the years, there has been an exponential increase in the number of gene therapy approaches that are under investigation for the treatment of cancer. This can be attributed to our growing understanding of the molecular mechanisms that contribute to the onset and maintenance of cancer as well as to the development of gene delivery vectors. In this review, we will focus on the use of lentiviral vectors (LVs) in immuno gene therapy of cancer, as these efficacious gene delivery vehicles have come to the forefront because of their many attractive features. LVs have been successfully applied to generate potent dendritic cellbased anti-cancer vaccines and to deliver cancer-specific receptors to T-cells. Moreover, LVs are under investigation for the modulation of cancer cells. We will describe various strategies of this ‘genuine’ cancer gene therapy, amongst which transfer of suicide genes, modulation of pro- and anti-apoptotic molecules, strategies to optimize chemo- and radiotherapy, expression of molecules that affect angiogenesis or affect the immunogenicity of tumor cells. These will be discussed in view of our current knowledge of tumor immunology. Finally we will discuss some important issues and future directions to push the field forward.
Export Options
About this article
Cite this article as:
Emeagi P.U., Goyvaerts C., Maenhout S., Pen J., Thielemans K. and Breckpot K., Lentiviral Vectors: A Versatile Tool to Fight Cancer, Current Molecular Medicine 2013; 13 (4) . https://dx.doi.org/10.2174/1566524011313040011
DOI https://dx.doi.org/10.2174/1566524011313040011 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Platelet-Neutrophil Interactions in Giant-Cell Arteritis
Current Pharmaceutical Design Amyloid A Amyloidosis Secondary to Rheumatoid Arthritis: An Uncommon Yet Important Complication
Current Rheumatology Reviews Pharmacovigilance and the Cardiovascular System: Two Sides to Every Story
Current Drug Safety Trials Comparing Percutaneous And Surgical Myocardial Revascularization: A Review
Reviews on Recent Clinical Trials Cardiac Regeneration: Stem Cells and Beyond
Current Medicinal Chemistry Microvascular Thrombosis: An Exciting but Elusive Therapeutic Target in Reperfused Acute Myocardial Infarction
Cardiovascular & Hematological Disorders-Drug Targets Role of Oxidative-Nitrosative Stress and Downstream Pathways in Various Forms of Cardiomyopathy and Heart Failure
Current Vascular Pharmacology Management of Osteoporosis: Seeing the Future
Medicinal Chemistry Reviews - Online (Discontinued) The Hydroxamic Acids as Potential Anticancer and Neuroprotective Agents
Current Medicinal Chemistry Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19
Current Cardiology Reviews Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Synthetic Genomics and Synthetic Biology Applications Between Hopes and Concerns
Current Genomics Liver Enzymes: Potential Cardiovascular Risk Markers?
Current Pharmaceutical Design Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy
Current Medicinal Chemistry Multi-target Activities of Selected Alkaloids and Terpenoids
Mini-Reviews in Organic Chemistry Intracellular Signaling of the Aging Suppressor Protein Klotho
Current Molecular Medicine Body Mass Index (BMI) and Cognitive Functions in Later Life
Current Alzheimer Research Policies to Prevent Tobacco Use and Exposure in Children, a Global Perspective
Current Pediatric Reviews Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population
Current Genomics Eisenmenger Syndrome: Recent Advances in Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry